DIAP2_HUMAN - dbPTM
DIAP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DIAP2_HUMAN
UniProt AC O60879
Protein Name Protein diaphanous homolog 2
Gene Name DIAPH2
Organism Homo sapiens (Human).
Sequence Length 1101
Subcellular Localization Isoform 3: Cytoplasm, cytosol. Early endosome. Isoform 3 is cytosolic but when coexpressed with RHOD, the 2 proteins colocalize to early endosomes.
Protein Description Could be involved in oogenesis. Involved in the regulation of endosome dynamics. Implicated in a novel signal transduction pathway, in which isoform 3 and CSK are sequentially activated by RHOD to regulate the motility of early endosomes through interactions with the actin cytoskeleton..
Protein Sequence MEQPGAAASGAGGGSEEPGGGRSNKRSAGNRAANEEETKNKPKLNIQIKTLADDVRDRITSFRKSTVKKEKPLIQHPIDSQVAMSEFPAAQPLYDERSLNLSEKEVLDLFEKMMEDMNLNEEKKAPLRNKDFTTKREMVVQYISATAKSGGLKNSKHECTLSSQEYVHELRSGISDEKLLNCLESLRVSLTSNPVSWVNNFGHEGLGLLLDELEKLLDKKQQENIDKKNQYKLIQCLKAFMNNKFGLQRILGDERSLLLLARAIDPKQPNMMTEIVKILSAICIVGEENILDKLLGAITTAAERNNRERFSPIVEGLENQEALQLQVACMQFINALVTSPYELDFRIHLRNEFLRSGLKTMLPDLKEKENDELDIQLKVFDENKEDDLTELSHRLNDIRAEMDDMNEVYHLLYNMLKDTAAENYFLSILQHFLLIRNDYYIRPQYYKIIEECVSQIVLHCSGMDPDFKYRQRLDIDLTHLIDSCVNKAKVEESEQKAAEFSKKFDEEFTARQEAQAELQKRDEKIKELEAEIQQLRTQAQVLSSSSGIPGPPAAPPLPGVGPPPPPPAPPLPGGAPLPPPPPPLPGMMGIPPPPPPPLLFGGPPPPPPLGGVPPPPGISLNLPYGMKQKKMYKPEVSMKRINWSKIEPTELSENCFWLRVKEDKFENPDLFAKLALNFATQIKVQKNAEALEEKKTGPTKKKVKELRILDPKTAQNLSIFLGSYRMPYEDIRNVILEVNEDMLSEALIQNLVKHLPEQKILNELAELKNEYDDLCEPEQFGVVMSSVKMLQPRLSSILFKLTFEEHINNIKPSIIAVTLACEELKKSESFNRLLELVLLVGNYMNSGSRNAQSLGFKINFLCKIRDTKSADQKTTLLHFIADICEEKYRDILKFPEELEHVESASKVSAQILKSNLASMEQQIVHLERDIKKFPQAENQHDKFVEKMTSFTKTAREQYEKLSTMHNNMMKLYENLGEYFIFDSKTVSIEEFFGDLNNFRTLFLEAVRENNKRREMEEKTRRAKLAKEKAEQEKLERQKKKKQLIDINKEGDETGVMDNLLEALQSGAAFRDRRKRIPRNPDNRRVPLERSRSRHNGAISSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEQPGAAA
-------CCCCCCCC
45.6922814378
15PhosphorylationASGAGGGSEEPGGGR
CCCCCCCCCCCCCCC
41.9028674151
23PhosphorylationEEPGGGRSNKRSAGN
CCCCCCCCCCCCCCC
50.4028674151
49UbiquitinationPKLNIQIKTLADDVR
CCCCEEEEHHHHHHH
22.5533845483
61PhosphorylationDVRDRITSFRKSTVK
HHHHHHHHHHHHCCC
22.2321712546
65PhosphorylationRITSFRKSTVKKEKP
HHHHHHHHCCCCCCC
33.8921712546
66PhosphorylationITSFRKSTVKKEKPL
HHHHHHHCCCCCCCC
39.10-
85PhosphorylationIDSQVAMSEFPAAQP
CCCHHHHCCCCCCCC
26.7529978859
94PhosphorylationFPAAQPLYDERSLNL
CCCCCCCCCCCCCCC
23.5728796482
123AcetylationDMNLNEEKKAPLRNK
HCCCCHHHCCCCCCC
48.3220167786
124AcetylationMNLNEEKKAPLRNKD
CCCCHHHCCCCCCCC
59.5220167786
130AcetylationKKAPLRNKDFTTKRE
HCCCCCCCCCCCCHH
48.0320167786
131 (in isoform 3)Phosphorylation-50.0729083192
133 (in isoform 3)Phosphorylation-41.3529083192
135 (in isoform 3)Phosphorylation-43.2229083192
138 (in isoform 3)Phosphorylation-4.0929083192
142 (in isoform 3)Phosphorylation-5.8029083192
145 (in isoform 3)Phosphorylation-11.3029083192
189PhosphorylationCLESLRVSLTSNPVS
HHHHHCCCCCCCCCH
21.35-
232AcetylationIDKKNQYKLIQCLKA
CCHHHHHHHHHHHHH
29.3825953088
238UbiquitinationYKLIQCLKAFMNNKF
HHHHHHHHHHHCCCC
47.40-
366UbiquitinationKTMLPDLKEKENDEL
HHHCCCHHHHCCCCC
74.2932015554
439PhosphorylationFLLIRNDYYIRPQYY
HHHHCCCCCCCHHHH
12.3526074081
440PhosphorylationLLIRNDYYIRPQYYK
HHHCCCCCCCHHHHH
8.0426074081
445PhosphorylationDYYIRPQYYKIIEEC
CCCCCHHHHHHHHHH
14.9226074081
446PhosphorylationYYIRPQYYKIIEECV
CCCCHHHHHHHHHHH
7.1726074081
454PhosphorylationKIIEECVSQIVLHCS
HHHHHHHHHHHHHHC
26.3326074081
503AcetylationKAAEFSKKFDEEFTA
HHHHHHHHHCHHHHH
57.7725953088
509PhosphorylationKKFDEEFTARQEAQA
HHHCHHHHHHHHHHH
24.98-
520UbiquitinationEAQAELQKRDEKIKE
HHHHHHHHHHHHHHH
74.5624816145
526UbiquitinationQKRDEKIKELEAEIQ
HHHHHHHHHHHHHHH
68.2824816145
632PhosphorylationGMKQKKMYKPEVSMK
CCCCCCCCCCCCCCC
32.0717081983
637PhosphorylationKMYKPEVSMKRINWS
CCCCCCCCCCCCCHH
19.5428857561
639AcetylationYKPEVSMKRINWSKI
CCCCCCCCCCCHHHC
42.4925953088
661UbiquitinationNCFWLRVKEDKFENP
CEEEEEECCCCCCCH
54.4829967540
700AcetylationEKKTGPTKKKVKELR
HHCCCCCHHHHEEEE
54.457695091
701AcetylationKKTGPTKKKVKELRI
HCCCCCHHHHEEEEE
66.3430588141
713PhosphorylationLRILDPKTAQNLSIF
EEECCHHHCCCHHHH
38.5727174698
718PhosphorylationPKTAQNLSIFLGSYR
HHHCCCHHHHHHCCC
20.8827174698
723PhosphorylationNLSIFLGSYRMPYED
CHHHHHHCCCCCHHH
16.2327174698
724PhosphorylationLSIFLGSYRMPYEDI
HHHHHHCCCCCHHHH
14.7727174698
728PhosphorylationLGSYRMPYEDIRNVI
HHCCCCCHHHHHHHH
19.5227174698
759UbiquitinationVKHLPEQKILNELAE
HHHCCHHHHHHHHHH
47.7232015554
813PhosphorylationHINNIKPSIIAVTLA
HHHHCCHHHHHHHHH
22.94-
875PhosphorylationKSADQKTTLLHFIAD
CCCCCHHHHHHHHHH
34.07-
949PhosphorylationKFVEKMTSFTKTARE
HHHHHHHHHHHHHHH
27.6724719451
970AcetylationTMHNNMMKLYENLGE
HHHHHHHHHHHHHHC
36.83126682799
1026UbiquitinationTRRAKLAKEKAEQEK
HHHHHHHHHHHHHHH
70.9024816145
1053PhosphorylationINKEGDETGVMDNLL
CCCCCCCCCHHHHHH
39.5524043423
1065PhosphorylationNLLEALQSGAAFRDR
HHHHHHHHCCHHHHH
31.1124043423

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DIAP2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DIAP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DIAP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RHOD_HUMANRHODphysical
12577064

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
300511Premature ovarian failure 2A (POF2A)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DIAP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-632, AND MASSSPECTROMETRY.

TOP